TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
H.B. Fuller Company (NYSE: FUL) has reportedly submitted a 285 pence-per-share cash offer to acquire Advanced Medical Solutions Group (LON: AMSU), intensifying takeover interest in the UK-based medical technology company. The proposed acquisition highlights growing consolidation in the healthcare and medical device sector during 2026.
The Minnesota-based adhesives manufacturer is currently conducting due diligence and holding discussions with Advanced Medical Solutions after making an unsolicited proposal on April 30, 2026. Under UK takeover regulations, H.B. Fuller must announce a firm intention to proceed with a formal bid or withdraw its interest by June 18, 2026.
According to reports, Goldman Sachs and Perella Weinberg Partners are advising H.B. Fuller on the potential transaction, while Ashurst LLP serves as legal counsel. Advanced Medical Solutions is being advised by Evercore Partners International and Investec Bank.
The possible acquisition comes shortly after private equity firm TA Associates ended its pursuit of Advanced Medical Solutions earlier this month. TA Associates had reportedly considered an offer near 280 pence per share, valuing the company at around £600 million. Before that, Montagu Private Equity also explored a potential bid but did not move forward.
Analysts believe Advanced Medical Solutions has become increasingly attractive following its 2024 acquisition of Peters Surgical, a France-based surgical products company. The deal significantly expanded AMSU’s manufacturing and sales capabilities across Europe and Asia.
The integration of Peters Surgical helped boost Advanced Medical Solutions’ 2025 revenue by 29% to £228.9 million, while adjusted EBITDA climbed 24% to £49.9 million. Industry experts suggest these stronger financial results and potential cost synergies could motivate strategic buyers like H.B. Fuller to pursue a takeover.
Despite ongoing negotiations, both companies emphasized that there is no certainty a final agreement will be reached. Investors continue monitoring developments closely as the June deadline approaches.
